Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro-Reference-Cited by-同舟云学术

Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro

Published:2021-04-06 Issue:11 Volume:178 Page:2339-2350
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Schloer Sebastian¹,Brunotte Linda²^ORCID,Mecate‐Zambrano Angeles²,Zheng Shuyu³,Tang Jing³^ORCID,Ludwig Stephan²^ORCID,Rescher Ursula¹^ORCID

Affiliation:

1. Institute of Medical Biochemistry, Center for Molecular Biology of Inflammation, and “Cells in Motion” Interfaculty Centre University of Muenster Muenster Germany

2. Institute of Virology, Center for Molecular Biology of Inflammation, and “Cells in Motion” Interfaculty Centre University of Muenster Muenster Germany

3. Research Program in Systems Oncology, Faculty of Medicine University of Helsinki Helsinki Finland

Funder

Academy of Finland

Deutsche Forschungsgemeinschaft

European Research Council

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15418

Reference52 articles.